|
- 品牌：Innovative Research of America
- 產(chǎn)地：國(guó)外
- 貨號(hào)：123
- 價(jià)格： ￥10/支
- 發(fā)布日期： 2023-08-03
- 更新日期： 2024-08-12
| 產(chǎn)地 | 國(guó)外 |
| 品牌 | Innovative Research of America |
| 貨號(hào) | 123 |
| 用途 | 科研 |
| 包裝規(guī)格 | 1g |
| CAS編號(hào) | |
| 純度 | 100% |
| 是否進(jìn)口 | 是 |
nnovative Research of America公司介紹：
Innovative Research of America(IRA) 是一家致力研發(fā)于藥物定量定時(shí)緩釋系統(tǒng)的專業(yè)化公司，又稱Matrix-Driven Delivery (MDD) 給藥系統(tǒng)。該給藥系統(tǒng)由一個(gè)可生物吸收的基質(zhì)組成，含有定量可控的活性給藥成分，可以以設(shè)定的劑量在一定時(shí)間范圍內(nèi)進(jìn)行給藥。給藥天數(shù)及劑量的選擇：依據(jù)研究人員實(shí)驗(yàn)需要確定，如某實(shí)驗(yàn)需要在3周內(nèi)給大鼠皮下給某種藥x mg，首先在本公司產(chǎn)品目錄中選取該種藥物，然后選取21天緩釋時(shí)間，劑量選擇可以如下方式進(jìn)行：21天共給藥量或每天給藥量，計(jì)算出總的藥物劑量。
Matrix-Driven Delivery (MDD) Pellet（MDD片劑）的優(yōu)勢(shì)：
Saves time
Ready-to-implant
Insures controlled product release over time
Avoids "peak and valley" effects
Guarantees consistent product preparation
Extends product life against spontaneous breakdown
Extends product life against host-related breakdown
Minimizes experimental variables
Insures safety of the experimenter
Reduces neurophysiological trauma to animal/no excessive handling
Generates more meaningful and reproducible results
Superior to conventional delivery methods
Enhances experimental efficiency
Frees valuable time for creative research
Saves money
Innovative Research of America的主要產(chǎn)品包括：
ANTIBIOTICS
ANTI-INFLAMMATORY AGENTS
ANTI-NEOPLASTICS
CATECHOLAMINES & RELATED PRODUCTS
CORTICOIDS & DIURETICS
ESTROGENS & ANTI-ESTROGENS
FATTY ACIDS
MISCELLANEOUS PRODUCTS
NUCLEOTIDE RELATED PRODUCTS
PLACEBO
PROGESTINS
PROSTAGLANDINS
THYROIDS
VITAMINS
